Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...

Only five of the 19 (27%) tumors were classified correctly by conventional ultrasound. Thirteen lesions (68%) could not be differentiated and one mass (5% ... showed small cystic areas at the ...

Renal ultrasound scans were available in all 67 cases (Figure 1A, B) and demonstrated a complex cystic mass in 49 cases. Renal CT scans were performed in 62 patients (Figure 1C), and a possible ...